PET Imaging Agent Earns FDA Fast Track Designation in Recurrent Glioma
TLX101 is currently under assessment as a treatment for glioma in the IPAX-2 and IPAX-Linz studies.
TLX101 is currently under assessment as a treatment for glioma in the IPAX-2 and IPAX-Linz studies.
The PCAR study aimed to assess the efficacy and safety of preoperative transcatheter rectal arterial chemoembolisation (TRACE) in patients with locally advanced rectal cancer (LARC).
What is neuroblastoma? Neuroblastoma is a childhood cancer that develops when neural crest cells do not mature properly and continue to proliferate in an imm…
On April 30, 2024, the U.S. FDA granted Orphan Drug Designation to IGNK001, an investigational allogeneic NK cell therapy derived from healthy donors, for the…
Follow a few easy steps to create a free account on NCCN.org. • Go to the NCCN.org homepage. https://www.nccn.org/home Then, click on “Create Account.” •…
The 15 inductees have been selected by their peers for their remarkable achievements in oncology research and clinical practice.
Cancer Cytopathology is an international cytopathology journal publishing research related to topics concerning the etiology of cancer, its diagnosis and prevention.
Previous research suggests people with subjective cognitive decline are 2.5 times more likely to develop dementia.
OPTYX is a multi-center, prospective, observational study designed to further understand the actual experience of patients with advanced prostate cancer treated with relugolix (ORGOVYX®), an…
Although immune checkpoint inhibitors have become a cornerstone of therapy across cancer settings, their use in most breast cancer settings has fallen short.
In this issue of Blood, Leung et al1 present preclinical findings demonstrating the potential of neoantigen-specific T cells to recognize acute myeloid leu